trial summary · NCT07746427
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Outcomes of a Digital Mindfulness Meditation App-Based Intervention in Adolescents With Moderate to Severe Atopic Dermatitis (MIND-AD)
Trial record from the TrialBase DB dataset, status RECRUITING, condition Atopic Dermatitis, sponsored by Weill Medical College of Cornell University. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.
Source record: https://clinicaltrials.gov/study/NCT07746427
Facts
| registry id | NCT07746427 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Atopic Dermatitis |
| sponsor | Weill Medical College of Cornell University |
| sponsor class | OTHER |
| enrollment | 40 |
| start date | 2026-11-15 |
| primary completion | 2028-07 |
| completion | 2028-07 |
| results posted | not reported |
Conditions
- Atopic Dermatitis
- Eczema
Interventions
- Digital App Mindfulness Meditation
- Mindfulness Meditation Sheet
Countries
- United States
Intervention types: BEHAVIORAL
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.